Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
12/2005
12/20/2005CA2159481C Tetracyclic compounds as dopamine agonists
12/15/2005WO2005118593A1 Bicyclic heterocycles as hiv integrase inhibitors
12/15/2005WO2005118566A1 Method for producing 1,3-dioxolan-4,6-dione compound
12/15/2005WO2005117986A2 Antibody drug conjugates and methods
12/15/2005WO2005117908A2 Triheterocyclic compounds compositions, and methods for treating cancer or viral diseases
12/15/2005WO2005117881A1 Process to prepare camptothecin derivatives and novel intermediate and compounds thereof
12/15/2005WO2005117879A1 Process to prepare camptothecin derivatives
12/15/2005WO2005117876A1 Dual small molecule inhibitors of cancer and angiogenesis
12/15/2005WO2005080357A3 Oxazole derivatives, preparation and therapeutic use therof
12/15/2005US20050277661 Inhibitors of the HIV integrase enzyme
12/15/2005US20050277659 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as ORL1-receptor antagonists
12/15/2005US20050277658 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 6,7-dimethoxy-4-(4-(benzodioxol-5-ylmethylaminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole
12/15/2005US20050277637 Arylindenopyridines and related therapeutic and prophylactic methods
12/15/2005US20050277630 Antibacterial agents
12/15/2005US20050276812 Antibody-drug conjugates and methods
12/15/2005DE102004026026A1 New 2-(hetero)aryl-tetrahydroquinoline derivatives and 1,2,3,4-tetrahydro-1,5-naphthyridine derivatives are mitotic motor protein Eg5 inhibitors used as anticancer agents for treating carcinoma or leukemia
12/15/2005CA2569266A1 Process to prepare camptothecin derivatives and novel intermediate and compounds thereof
12/15/2005CA2568622A1 Dual small molecule inhibitors of cancer and angiogenesis
12/15/2005CA2568523A1 Process to prepare camptothecin derivatives
12/15/2005CA2567520A1 Maytansinoid-antibody conjugates
12/14/2005EP1604983A1 Receptor antagonist
12/14/2005EP1604653A1 Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder
12/14/2005EP1603919A1 7-imino derivatives of camptothecin having antitumor activity
12/14/2005EP1603901A1 Tetrahydropyran compounds as tachykinin antagonists
12/14/2005EP1603883A2 Quinoline-derived amide modulators of vanilloid vr1 receptor
12/14/2005EP1603568A2 Isoquinoline derivatives and methods of use thereof
12/14/2005EP1603567A2 Tetracyclic benzamide derivatives and methods of use thereof
12/14/2005EP1603555A2 Halogenated triptolide derivatives as immunomodulators and anticancer agents
12/14/2005EP1066258B1 Aryl phenyl substituted cyclic ketoenols
12/14/2005CN1708481A N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials
12/14/2005CN1706845A Thiophosphoric acid derivative of quaternary ammonium chelidonium alkaloid
12/14/2005CN1231484C Benzo [b] pyran-[3,2-h] acridinyl-7-one compounds, their prepn and medicine composition containing them
12/14/2005CN1231470C N-alkoxy-4, 4-dioxy-polyalkyl-piperidines as polymerisation in hibitors
12/14/2005CN1231467C High affinity ligands for nociceptin receptor ORL-1
12/13/2005US6974827 For use as pesticides and herbicides
12/08/2005WO2005115977A1 Pyrrolidine derivatives as cb1-receptor antagonists
12/08/2005WO2005115398A2 Hiv integrase inhibitors
12/08/2005WO2005089294A3 Synthesis of indenoisoquinoliniums and methods of use
12/08/2005WO2005062894A3 Co-administration of dopamine-receptor binding compounds
12/08/2005WO2005047526A3 Method for identifying inhibitors using a homology model of polo-like kinase 1
12/08/2005WO2004096139A8 Aza spiro alkane derivatives as inhibitors of metalloproteases
12/08/2005WO2004093805A3 Selective spirocyclic glucocorticoid receptor modulators
12/08/2005US20050272799 Fused Heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
12/08/2005US20050272763 antagonists of the Cannabinoid-1 (CB1) receptor; treating obesity
12/08/2005US20050272762 Thienopyridines as IKK inhibitors
12/08/2005US20050272757 Process to prepare camptothecin derivatives and novel intermediate and compounds thereof
12/08/2005US20050272736 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
12/08/2005US20050272730 Thienopyridazines as IKK inhibitors
12/08/2005US20050272716 Use of parthenolide derivatives as antileukemic and cytotoxic agents
12/08/2005US20050272133 A C9-deoxomeridamycin, used as a neuroregenerative agent
12/07/2005EP1601673A1 Novel fused heterocycles and uses thereof
12/07/2005EP1527053B1 Process for preparing rizatriptan
12/07/2005EP1296987B1 Compounds for treating impaired fundic relaxation
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP0949920B1 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
12/07/2005CN1705672A New benzodioxino-isoindole derivatives, useful for treatment of cancer, are inhibitors of cell cycle
12/07/2005CN1705658A Process for making spirolactone compounds
12/07/2005CN1705647A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/07/2005CN1704416A Novel camptothecin derivatives and their preparation process and use
12/07/2005CN1704404A Tricyclic protein kinase inhibitors
12/07/2005CN1230437C Synthetic process for intermediate for ecteinascidin and phthalascidin compounds
12/07/2005CN1230424C Hydroxy substituted N-alkoxy hindered amine
12/07/2005CN1230421C Amide compounds and medicinal use thereof
12/06/2005US6972299 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
12/01/2005WO2005113562A1 Hiv integrase inhibitors: cyclic pyrimidinone compounds
12/01/2005WO2005113558A2 Simple stereocontrolled synthesis of salinosporamide a
12/01/2005WO2005113542A2 N-cyclic sulfonamido inhibitors of gamma secretase
12/01/2005WO2005113536A2 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
12/01/2005WO2005113509A1 Novel 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
12/01/2005WO2005113501A1 Neurogenic pain control agent composition
12/01/2005WO2005060963A8 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
12/01/2005US20050267194 Indole compounds
12/01/2005US20050267147 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
12/01/2005US20050267142 Adenosine A2a receptors antagonist; 9H-indeno[2,1-c]pyridine-4-carboxylic acid, 3-amino-1-furan-2-yl-9-oxo-, 2-dimethylamino-ethyl ester; neurodegenerative and movement disease, as Parkinson's; improves binding affinity of Dopamine D2 agonist to their receptors
12/01/2005US20050267141 Process to prepare camptothecin derivatives
12/01/2005US20050267139 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
12/01/2005US20050267138 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
12/01/2005US20050267108 Treatment of peroxisome proliferation activated receptor diseases such as diabetes, skin disorders or high blood pressure
12/01/2005US20050267105 Bicyclic heterocycles as HIV integrase inhibitors
12/01/2005US20050267073 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
12/01/2005US20050267043 Novel inhibitors of hepatitis C virus NS3 protease
12/01/2005CA2567343A1 N-cyclic sulfonamido inhibitors of gamma secretase
12/01/2005CA2566755A1 Hiv integrase inhibitors: cyclic pyrimidinone compounds
12/01/2005CA2563968A1 Neurogenic pain control agent composition
11/2005
11/30/2005EP1599484A2 Process for the preparation of hexacyclic camptothecin derivatives
11/30/2005EP1599469A1 Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
11/30/2005EP1599465A1 Substituted n-aryl nitrogen heterocycles
11/30/2005EP1599167A2 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
11/30/2005EP1401839B9 Antidepressant (sssri) azaheterocyclymethyl derivatives of 7,8-dihydro-3h-t,9-dioxa-1,3-diazacyclopenta [a] naphthalene
11/30/2005EP1313740B1 Prodrugs of imidazopyridine derivatives
11/30/2005EP0963200B9 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid
11/30/2005EP0871631B1 Antiparasitic marcfortines and paraherquamides
11/30/2005CN1703412A Novel compounds with antibacterial activity
11/30/2005CN1703403A Metabotropic glutamate receptor antagonists
11/30/2005CN1229382C Hemisynthetic method and intermediate thereof
11/30/2005CN1229323C Dialkoyl-halogen phenyl substituted keto-enol
11/29/2005US6969730 Amines as histamine-3 receptor ligands and their therapeutic applications
11/29/2005CA2332513C New derivatives of 4-sulfonamide piperidine, preparation process thereof and the pharmaceutical compositions they contain
11/24/2005WO2005111044A1 4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones
1 ... 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 ... 298